Standardized β-coefficients for associations between MVPA (min ⋅ day−1) and cardiometabolic risk factors
| Characteristics . | β . | 95% CI . | P . | R2 . |
|---|---|---|---|---|
| Model 1 | ||||
| Waist (cm) | −0.177 | −0.122, −0.134 | *** | 0.2046 |
| Systolic BP (mmHg) | −0.005 | −0.047, 0.083 | 0.1915 | |
| Diastolic BP (mmHg) | −0.007 | −0.044, 0.031 | 0.3441 | |
| Fasting insulin (mU ⋅ L−1) | −0.115 | −0.158, −0.072 | *** | 0.1237 |
| Fasting glucose (mmol ⋅ L−1) | −0.028 | −0.072, 0.017 | 0.1645 | |
| 2-h plasma glucose (mmol ⋅ L−1) | −0.069 | −0.112, −0.025 | ** | 0.1108 |
| HbA1c (%) | −0.046 | −0.096, 0.004 | 0.1334 | |
| HOMA-IR | −0.122 | −0.166, −0.078 | *** | 0.1235 |
| Triglycerides (mmol ⋅ L−1) | −0.091 | −0.138, −0.044 | *** | 0.0762 |
| Total cholesterol (mmol ⋅ L−1) | −0.01 | −0.056, 0.035 | 0.0952 | |
| HDL (mmol ⋅ L−1) | 0.055 | 0.009, 0.101 | * | 0.1808 |
| LDL (mmol ⋅ L−1) | 0.002 | −0.044, 0.048 | 0.0567 | |
| CRP (mg ⋅ L−1) | −0.086 | −0.127, −0.045 | *** | 0.262 |
| Model 2 | ||||
| Waist (cm) | −0.127 | −0.173, −0.081 | *** | 0.2215 |
| Systolic BP (mmHg) | 0.02 | −0.026, 0.067 | 0.1961 | |
| Diastolic BP (mmHg) | 0.011 | −0.03, 0.053 | 0.3467 | |
| Fasting insulin (mU ⋅ L−1) main effect | −0.078 | −0.127, −0.03 | ** | 0.1337 |
| 25–45.9 years (reference) | — | — | — | — |
| 46.0–54.9 years | 0.025 | −0.120, 0.170 | 0.1313 | |
| 55.0–71 years | −0.098 | −0.195, −0.001 | * | 0.1313 |
| Fasting glucose (mmol ⋅ L−1) | −0.014 | −0.063, 0.035 | 0.1659 | |
| 2-h plasma glucose (mmol ⋅ L−1) | −0.053 | −0.1, −0.006 | * | 0.1129 |
| HbA1c (%) | −0.036 | −0.095, 0.023 | 0.1345 | |
| HOMA-IR | −0.08 | −0.129, −0.031 | ** | 0.1368 |
| Triglycerides (mmol ⋅ L−1) | −0.067 | −0.117, −0.017 | ** | 0.0804 |
| Cholesterol (mmol ⋅ L−1) | −0.013 | −0.064, 0.037 | 0.0953 | |
| HDL (mmol ⋅ L−1) | 0.028 | −0.081, 0.383 | 0.1867 | |
| LDL (mmol ⋅ L−1) | 0 | −0.053, −0.052 | 0.0572 | |
| CRP (mmol ⋅ L−1) | −0.061 | −0.108, −0.015 | ** | 0.2665 |
| Characteristics . | β . | 95% CI . | P . | R2 . |
|---|---|---|---|---|
| Model 1 | ||||
| Waist (cm) | −0.177 | −0.122, −0.134 | *** | 0.2046 |
| Systolic BP (mmHg) | −0.005 | −0.047, 0.083 | 0.1915 | |
| Diastolic BP (mmHg) | −0.007 | −0.044, 0.031 | 0.3441 | |
| Fasting insulin (mU ⋅ L−1) | −0.115 | −0.158, −0.072 | *** | 0.1237 |
| Fasting glucose (mmol ⋅ L−1) | −0.028 | −0.072, 0.017 | 0.1645 | |
| 2-h plasma glucose (mmol ⋅ L−1) | −0.069 | −0.112, −0.025 | ** | 0.1108 |
| HbA1c (%) | −0.046 | −0.096, 0.004 | 0.1334 | |
| HOMA-IR | −0.122 | −0.166, −0.078 | *** | 0.1235 |
| Triglycerides (mmol ⋅ L−1) | −0.091 | −0.138, −0.044 | *** | 0.0762 |
| Total cholesterol (mmol ⋅ L−1) | −0.01 | −0.056, 0.035 | 0.0952 | |
| HDL (mmol ⋅ L−1) | 0.055 | 0.009, 0.101 | * | 0.1808 |
| LDL (mmol ⋅ L−1) | 0.002 | −0.044, 0.048 | 0.0567 | |
| CRP (mg ⋅ L−1) | −0.086 | −0.127, −0.045 | *** | 0.262 |
| Model 2 | ||||
| Waist (cm) | −0.127 | −0.173, −0.081 | *** | 0.2215 |
| Systolic BP (mmHg) | 0.02 | −0.026, 0.067 | 0.1961 | |
| Diastolic BP (mmHg) | 0.011 | −0.03, 0.053 | 0.3467 | |
| Fasting insulin (mU ⋅ L−1) main effect | −0.078 | −0.127, −0.03 | ** | 0.1337 |
| 25–45.9 years (reference) | — | — | — | — |
| 46.0–54.9 years | 0.025 | −0.120, 0.170 | 0.1313 | |
| 55.0–71 years | −0.098 | −0.195, −0.001 | * | 0.1313 |
| Fasting glucose (mmol ⋅ L−1) | −0.014 | −0.063, 0.035 | 0.1659 | |
| 2-h plasma glucose (mmol ⋅ L−1) | −0.053 | −0.1, −0.006 | * | 0.1129 |
| HbA1c (%) | −0.036 | −0.095, 0.023 | 0.1345 | |
| HOMA-IR | −0.08 | −0.129, −0.031 | ** | 0.1368 |
| Triglycerides (mmol ⋅ L−1) | −0.067 | −0.117, −0.017 | ** | 0.0804 |
| Cholesterol (mmol ⋅ L−1) | −0.013 | −0.064, 0.037 | 0.0953 | |
| HDL (mmol ⋅ L−1) | 0.028 | −0.081, 0.383 | 0.1867 | |
| LDL (mmol ⋅ L−1) | 0 | −0.053, −0.052 | 0.0572 | |
| CRP (mmol ⋅ L−1) | −0.061 | −0.108, −0.015 | ** | 0.2665 |
Model 1 adjusted for age, sex, ethnicity, smoking, household income, education level, body fat%, wear time, sleep time, and intervention center. Model 2 additionally adjusted for ST.
*P < 0.05;
**P < 0.01;
***P < 0.001.